image
Galmed Pharmaceuticals Ltd. GLMD
Healthcare - Biotechnology - NASDAQ - IL
Watchlist
$ 1.37
-5.52 %
$ 3.09 M
Market Cap
-0.21
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
34.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Galmed Pharmaceuticals Ltd.
image
GLMD has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart GLMD

image
$18.0m$18.0m$16.0m$16.0m$14.0m$14.0m$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.020162016201720172018201820232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart GLMD

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)20162016201720172018201820232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart GLMD

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)20162016201720172018201820232023202420242025202520262026202720272028202820292029